Skip to main content
. 2021 Jun 3;45(8):1687–1695. doi: 10.1038/s41366-021-00831-4

Fig. 1. Patient disposition of populations of interest.

Fig. 1

Total population includes all patients from LIGHT who were on a DPP-4i or GLP-1RA at baseline and received study treatment. Week 52 completers are those in the total population who remained on study therapy at week 52. Week 16 responders are those in the total population who experienced a weight loss of at least 5% at week 16.